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Abstract
Thyrotoxic hypokalemic periodic paralysis (THPP) is a rare, potentially life-threatening endocrine emergency. It is
characterized by recurrent muscle weakness and hypokalemia. Because many THPP patients do not have obvious
symptoms and signs of hyperthyroidism, misdiagnosis may occur. The published studies revealed that definitive
therapy for THPP is control of hyperthyroidism by medical therapy, radioactive iodine or surgery, but the long-term
post-operative follow-up result was not observed. We reported two cases of medically refractory THPP with
recurrent paralysis of extremities and hypokalemia, and both were combined with thyroid nodules. Both patients
were treated with total thyroidectomy; the pathology revealed that one is Graves’ disease with thyroid papillary
carcinoma, and the other is adenomatous goiter with papillary hyperplasia. No episode of periodic paralysis was
noted and laboratory evaluation revealed normal potassium level during the post-operative follow up. Our
experience suggests that total thyroidectomy by experienced surgeon is an appropriate and definite treatment for
medically refractory THPP, especially in cases combined with thyroid nodules.
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Background
Thyrotoxic hypokalemic periodic paralysis (THPP) is a rare
endocrine disorder and a reversible medical emergency.
The incidence of THPP in Asians, the most frequently
affected population, is approximately 2%, while THPP is
largely unknown in the West, although the number of
reported cases in Western countries has increased recently
in the literature [1]. Recent papers show a tendency towards
male predominance [2,3]. In Asian populations, THPP
usually appears between the ages of 20 and 40 years of life
[4], coinciding with the main age for hyperthyroidism.
Hypokalemia with associated flaccid paralysis and signs
of hyperthyroidism are the hallmarks of THPP. Hypoka-
lemia occurs due to a massive shift of potassium into the
cells rather than net loss from the body. Excess thyroid
hormone may predispose to paralytic episodes by
increasing the susceptibility of epinephrine or insulin,
and therefore increasing Na-K-ATPase activity in the
beta-adrenergic receptors in skeletal muscles, which
leads to potassium shift into the cells [5].
The published studies revealed that the definitive therapy
for THPP is control of hyperthyroidism by medical ther-
apy, radioactive iodine or surgery, but the long-term post-
operative follow-up result was not observed. We reported
two cases of medically refractory THPP with recurrent
paralysis of extremities and hypokalemia, and both were
combined with thyroid nodules. After definite treatment by
total thyroidectomy, none of them experienced recurrent
THPP episodes during long term follow up.
Case presentation
Case 1
A 33-year-old male without significant past medical his-
tory presented to the emergency department with sudden
onset weakness of bilateral lower extremities. This was
the third episode in the previous two weeks despite medi-
cation. Prior to the episode, the patient had suffered from
hand tremors, palpitations, sweating, body weight loss,
good appetite, and anxiety for a period of time. His sister
had been diagnosed with hyperthyroidism but his family
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cal examination and laboratory study, the patient was
diagnosed with hypokalemic periodic paralysis associated
with Graves’ disease. After initiation of intravenous
potassium replacement, the patient’sn e u r o l o g i cs y m p -
toms completely resolved.
Reviewing the medical record, the patient received medi-
cation for several months, including potassium chloride
(600 mg/tid) for hypokalemia, methimazole (30 mg/day)
to control his underlying hyperthyroidism, and proprano-
lol (80 mg/day) to control blood pressure and tachycardia.
Despite these medications, the patient still suffered from
three attack episodes.
We arranged thyroid ultrasonography for this patient,
and this revealed focally heterogeneous hypoechoic
nodules with calcification, and fine needle aspiration
biopsy (FNAB) showed atypia cells. Neck computed
tomography (CT) survey also revealed multiple punctuate
calcifications in heterogeneous thyroid nodules, which
represent an increased risk of thyroid malignancy [6].
Due to FNAB and CT findings, the impression was highly
suspected thyroid cancer. Total thyroidectomy was per-
formed for this patient under the impression of Graves’
disease with suspected thyroid cancer, and the pathology
revealed papillary thyroid carcinoma. After operation, no
recurrence of periodic paralysis occurred and laboratory
evaluation revealed normal potassium level during the
ten years of follow-up period.
Case 2
A 52-year-old male had past medical history of alcoholic
liver cirrhosis and type 2 diabetes mellitus. He suffered
from sudden onset generalized weakness especially of the
bilateral lower extremities, and he had presented to the
emergency department four times in the previous five
years. The patient had hand tremors, but he denied any
other symptoms and signs of hyperthyroidism. None of
his family members had a history of similar episodes or
other significant illnesses. The patient was diagnosed with
hypokalemic periodic paralysis associated with hyperthyr-
oidism, and the patient’s neurologic symptoms completely
resolved after intravenous potassium replacement. Thyroid
ultrasonography revealed diffuse heterogeneous goiter.
Reviewing the medical record, the patient have received
medication for four years, including treatment for hypoka-
lemia with potassium chloride (600 mg/tid), and for thyro-
toxicosis with propranolol (80 mg/day) and methimazole
(30 mg/day). Despite of these medications, the patient still
suffered from recurrent attack episodes. Since thyroid
enlargement persisted despite the medication, annual fol-
low-up thyroid ultrasonography revealed diffuse heteroge-
neous goiter with a left neck lymphadenopathy, and FNAB
showed thyroid atypia cells with lymphadenopathy, total
thyroidectomy was performed about five years after the
initial hypokalemic paralysis attack. Pathology revealed
adenomatous goiter with papillary hyperplasia, and lymph
node with reactive hyperplasia. After operation, no episode
of periodic paralysis was noted and laboratory evaluation
revealed normal potassium level during the two years of
the follow-up period.
Discussion
THPP does not usually recur once the patient is euthyroid,
except in a few studied cases [2]. Adequate control of
hyperthyroidism is the mainstay of therapy. Hsieh et al [7]
reported that before achieving the euthyroid status, the
rate of recurrent attacks was as high as 62.2%, peaking in
the first 3 months after THPP diagnosis. The published
studies revealed long-term control treatment for THPP is
control of hyperthyroidism by medical therapy with
antithyroid drugs [7,8] and nonselective beta-blockers
[9,10], radioactive iodine [1,2,8-11] or surgery (thyroidect-
omy [1,7-10] or subtotal thyroidectomy [11]). Since failure
to properly diagnose and treat THPP can be fatal, rapid
correction of potassium abnormalities is imperative as it
can resolve the symptoms quickly and completely, and
definitive treatment depends on the underlying etiology.
In our experience of these two cases, we find total thyr-
oidectomy for treatment of medically refractory THPP
may have the following advantages: it can offer a definitive
control of hyperthyroidism and the coexisting thyroid dis-
order, such as Graves’ disease or benign/malignant goiter,
can also be treated. We believe that surgery is better than
radioactive iodine treatment because the latter has the risk
of radiation exposure. We also suggest total thyroidectomy
rather than subtotal thyroidectomy because of the possibi-
l i t yo fr e c u r r e n c eo ft h y r o i dt u m o rw h i c hm a yl e a dt o
THPP attack if the patient still has hyperthyroidism, or
which may render revision surgery more difficult. How-
ever, this procedure should be performed by experienced
surgeons to minimize the surgical complications such as
recurrent laryngeal nerve injury, hematoma with or with-
out airway obstruction and hypoparathyroidism. There-
fore, we suggest that total thyroidectomy by experienced
surgeons is an appropriate and definite treatment for
THPP.
Conclusions
We reported two cases of medically refractory THPP;
n e i t h e ro fw h o ms u f f e r e df r o mr e c u r r e n te p i s o d e so f
paralysis during the long-term follow up after total thyroi-
dectomy. Since failure to properly diagnose and treat
THPP can be fatal, rapid correction of potassium abnorm-
alities is imperative as it can resolve the symptoms quickly
and completely. Thus, we suggest total thyroidectomy as
the definitive therapy for THPP, and the coexisting thyroid
disorder, such as Graves’ disease or benign/malignant goi-
ter, can also be treated. We believe that total
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due to there being no risk of radiation exposure, and that
it is superior to subtotal thyroidectomy due to the lesser
risk of thyroid tumor recurrence. Although total thyroi-
dectomy may have certain surgical complications, we sug-
gest that total thyroidectomy by experienced thyroid
surgeons is an appropriate and definite treatment for
THPP.
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